Post date July 6, 2021 Experience Aligos Therapeutics $83.6 million follow-on offering We advised the underwriters on the stock offering
Post date July 6, 2021 Experience Xometry $347.9 million IPO We advised the underwriters on the IPO and Nasdaq listing
Post date June 29, 2021 Experience Theravance Biopharma $100.5 million follow-on offering We advised the underwriters on the equity offering
Post date June 11, 2021 Experience Etsy $1 billion convertible senior notes offering The Rule 144A offering involved 0.25% convertible notes due 2028
Post date May 24, 2021 Experience Sun Country Airlines $250.1 million secondary offering We advised the underwriters on the stock offering
Post date May 14, 2021 Experience Automatic Data Processing $1 billion notes offering We advised Automatic Data Processing on an investment-grade notes offering
Post date April 20, 2021 Experience Recursion Pharmaceuticals $500 million IPO We advised the underwriters on the IPO and Nasdaq listing
Post date March 23, 2021 Experience Anthem $3.5 billion senior notes offering We advised the underwriters on the investment-grade debt offering
Post date March 12, 2021 Experience Jounce Therapeutics $64.7 million follow-on offering We advised the underwriters on the equity offering
Post date February 8, 2021 Experience Revolution Medicines $300 million follow-on offering We advised the underwriters in connection with the equity offering